Large-Vessel Stroke and COVID-19 in Young Patients: New Insights
Cerebrovascular stroke specialists at the Icahn School of Medicine at Mount Sinai have reported on five patients younger than 50 years of age who presented to the Mount Sinai Health System in New York City with large-vessel stroke and COVID-19,...
Some Severely Ill Children May Mount an Overly Aggressive Response to COVID-19
Nine pediatric patients admitted to The Mount Sinai Hospital during the past two weeks, who either tested positive for COVID-19 or had antibodies, had severe abdominal pain and low blood pressure, which progressed to shock. Some of the patients also had...
Outcomes Data Published from Large, Diverse COVID-19 Patient Study in NYC
Sema4 scientists released results from an analysis of patients tested for SARS-CoV-2 at five hospitals in the Mount Sinai Health System. Spanning more than 28,000 patients, this is one of the largest and most racially diverse COVID-19 studies performed in...
Renowned Immunologist Miriam Merad, MD, PhD, is Elected to the National Academy of Science
Miriam Merad, MD, PhD, a pioneering immunologist at the Icahn School of Medicine at Mount Sinai, has been elected to the National Academy of Science (NAS), an honor that recognizes her transformational contributions to the fields of myeloid cell biology...
Did SARS-CoV-2 Emerge From Nature or a Lab?
Did the SARS-CoV-2 virus emerge in the human population spontaneously or was it engineered in a laboratory? Several months into this pandemic, there are still many more questions than answers about this stealthy new coronavirus that has commandeered the...
Mount Sinai Develops ‘Pseudo Virus’ to Assess the Effectiveness of Antibodies
As governments make plans to reopen their economies and seek reliable ways to ensure their populations can get back to work safely, high-quality antibody testing has emerged as the only way to truly determine which individuals may be protected against the...
Students, Postdoctoral Fellows, and Faculty Team Up to Advance Immunology Research on COVID-19
The unprecedented generation of non-peer-reviewed scientific information about COVID-19 in just a few months helped galvanize more than 50 members of the Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai into forming a group to...
Mount Sinai’s Antibody Test for COVID-19 Receives Emergency Use Authorization from FDA
A renowned team of virologists, pathologists, and clinicians at the Mount Sinai Health System developed, validated, and launched a blood test for COVID-19 antibodies that received the U.S. Food and Drug Administration’s (FDA) emergency use authorization...
Preliminary Case Series Leads to New Questions About the Disease Progression of COVID-19 in Patients with Blood Clots in the Lung
A small, preliminary case series led by physicians at the Icahn School of Medicine at Mount Sinai found that five severely ill patients with the SARS-CoV-2 virus responded to the blood-clot-busting drug tPA when it was introduced as a life-saving measure....